60 related articles for article (PubMed ID: 31916121)
1. Effect of proton pump inhibitors on high-dose methotrexate elimination: a systematic review and meta-analysis.
Wang X; Song Y; Wang J; He J; Liu R; Li X; Huang H; Zhang J
Int J Clin Pharm; 2020 Feb; 42(1):23-30. PubMed ID: 31916121
[TBL] [Abstract][Full Text] [Related]
2. Contribution of aldehyde oxidase to methotrexate-induced hepatotoxicity: in vitro and pharmacoepidemiological approaches.
Moriyama A; Ueda H; Narumi K; Asano S; Furugen A; Saito Y; Kobayashi M
Expert Opin Drug Metab Toxicol; 2024 May; 20(5):399-406. PubMed ID: 38706380
[TBL] [Abstract][Full Text] [Related]
3. Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy.
Ogawa A; Kawamoto H; Hara J; Kikuta A; Ogawa C; Hiraga H; Yoshimura K; Miyairi K; Omori R; Ro T; Kamei Y; Kimura T
Cancer Chemother Pharmacol; 2024 Mar; ():. PubMed ID: 38478074
[TBL] [Abstract][Full Text] [Related]
4. Oral regimen for high dose methotrexate urine alkalinization: a systematic review and meta-analysis.
Kaveh-Ahangaran R; Abdollahi M; Vaezi M; Kasaeian A; Bahlouli Z; Janbabaei G; Mojtahedzadeh A; Mojtahedzadeh M; Djalalinia S; Shahrami B
Daru; 2024 Jun; 32(1):353-377. PubMed ID: 38233724
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal Cancer.
Wu CC; Fang CY; Yu BH; Chang CM; Hsu TW; Hung CL; Hung SK; Chiou WY; Tsai JH
Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958477
[TBL] [Abstract][Full Text] [Related]
6. Comment on "Do proton pump inhibitors increase the risk of dementia? A systematic review, meta-analysis and bias analysis".
Lai SW; Hwang BF; Liu CS; Liao KF
Br J Clin Pharmacol; 2023 Dec; 89(12):3769-3770. PubMed ID: 37731208
[No Abstract] [Full Text] [Related]
7. Screening of cytoprotectors against methotrexate-induced cytogenotoxicity from bioactive phytochemicals.
Gu S; Wu Y; Yang J
PeerJ; 2016; 4():e1983. PubMed ID: 27190706
[TBL] [Abstract][Full Text] [Related]
8. Inappropriate use of proton pump inhibitors in clinical practice globally: a systematic review and meta-analysis.
Dutta AK; Sharma V; Jain A; Elhence A; Panigrahi MK; Mohta S; Kirubakaran R; Philip M; Goenka M; Bhatia S; Dutta U; Reddy DN; Kochhar R; Makharia GK
Gut; 2024 Apr; ():. PubMed ID: 38670630
[No Abstract] [Full Text] [Related]
9. The association between proton pump inhibitor use and systemic anti-tumour therapy on survival outcomes in patients with advanced non-small cell lung cancer: A systematic review and meta-analysis.
Br J Clin Pharmacol; 2024 May; 90(5):1371. PubMed ID: 38570720
[No Abstract] [Full Text] [Related]
10. The Complex Interaction between Proton Pump Inhibitors and Cancer Treatment.
Chen H; Kondo M; Horita N; Takahashi K; Kaneko T
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001605
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitors: Seeking the golden ratio between gastroprotection and cardiovascular risk.
Tsiartas E; Papazoglou AS
Eur Heart J Cardiovasc Pharmacother; 2024 May; ():. PubMed ID: 38749542
[No Abstract] [Full Text] [Related]
12. Proton Pump Inhibitors and CKD: The Evidence Builds.
Grams ME; Wilson FP
J Am Soc Nephrol; 2024 May; ():. PubMed ID: 38809613
[No Abstract] [Full Text] [Related]
13. Evaluation of possible pharmacokinetic interaction between methotrexate and proton pump inhibitors in rats.
Ueda H; Narumi K; Sato Y; Furugen A; Kobayashi M; Iseki K
Pharmacol Rep; 2020 Oct; 72(5):1426-1432. PubMed ID: 32671657
[TBL] [Abstract][Full Text] [Related]
14. Risk of Hospitalization With Hemorrhage Among Older Adults Taking Clarithromycin vs Azithromycin and Direct Oral Anticoagulants.
Hill K; Sucha E; Rhodes E; Carrier M; Garg AX; Harel Z; Hundemer GL; Clark EG; Knoll G; McArthur E; Sood MM
JAMA Intern Med; 2020 Aug; 180(8):1052-1060. PubMed ID: 32511684
[TBL] [Abstract][Full Text] [Related]
15. Clinical Impact of Co-medication of Levetiracetam and Clobazam with Proton Pump Inhibitors: A Drug Interaction Study.
Pasupuleti B; Gone V; Baddam R; Venisetty RK; Prasad OP
Curr Drug Metab; 2020; 21(2):126-131. PubMed ID: 32067615
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors associated with pemetrexed acute toxicity.
Bonnet M; Jouinot A; Boudou-Rouquette P; Seif V; Villeminey C; Arrondeau J; Vidal M; Batista R; Wislez M; Blanchet B; Goldwasser F; Thomas-Schoemann A
Eur J Clin Pharmacol; 2023 May; 79(5):635-641. PubMed ID: 36951965
[TBL] [Abstract][Full Text] [Related]
17. Drug-drug interactions with proton pump inhibitors in cancer patients: an underrecognized cause of treatment failure.
Raoul JL; Moreau-Bachelard C; Gilabert M; Edeline J; Frénel JS
ESMO Open; 2023 Feb; 8(1):100880. PubMed ID: 36764092
[TBL] [Abstract][Full Text] [Related]
18. Acute kidney injury and delayed methotrexate clearance in an adult patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia treated with imatinib.
Chen C; Qi J; Li X; Yongjing W
Eur J Hosp Pharm; 2023 Sep; 30(5):e28. PubMed ID: 36732034
[TBL] [Abstract][Full Text] [Related]
19. Proton Pump Inhibitors and Cancer: Current State of Play.
Bridoux M; Simon N; Turpin A
Front Pharmacol; 2022; 13():798272. PubMed ID: 35359844
[No Abstract] [Full Text] [Related]
20. Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy.
Cattaneo D; Pasina L; Maggioni AP; Giacomelli A; Oreni L; Covizzi A; Bradanini L; Schiuma M; Antinori S; Ridolfo A; Gervasoni C
Drugs Aging; 2020 Dec; 37(12):925-933. PubMed ID: 33150470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
